PWH (n=48)
Sex
Female 9 (18.8%)
Male 39 (81.2%)
Age, (years)* 46.3 (12.8)
On antiretroviral therapy 48 (100%)
InSTI 34 (77.3%)
NNRTI 7 (15.9%)
PI 9 (20.4%)
NRTI Backbone 42 (87.5%)
TDF-TAF/FTC-3TC 26 (54.2%)
ABC/FTC-3TC 9 (18.8%)
3TC-FTC 7 (14.6%)
Plasma HIV viral load (copies/mL) <20·0§
CD4+ T cell count per µL* 798 (271)
<350 per µL 2 (4.17%)
350-500 per µL 5 (10.4%)
>500 per µL 41 (85.4%)
CD4+ T cell count percentage* 35.3 (14.35)
CD4+ T/CD8 cells ratio 0.98 (0.64)
CD4+ T/CD8 ratio >=1 23 (47.9%)
CD4+ T/CD8 ratio >=0·4 41 (85.4%)
OIR 19 (39.6%)
HCV-Ab positive 2 (4.2%)
HBsAg positive 2 (4.2%)
CMV IgG positive 27 (77.1%)
Years since diagnosis 6 (10)
CD4+ T cell count per µL at nadir* 254 (190)
Plasma HIV viral load at zenith 99692 (164664)
AIDS diagnosis 11 (22.9%)
SARS-CoV-2 anti-N Ig positive 7 (14.6%)
VB in the preceding 12 months 11 (22.9%)